PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Beta-blockers before surgery appear associated with lower risk of heart-related events

2013-11-19
(Press-News.org) Contact information: Charlotte Andersson
ca@heart.dk
The JAMA Network Journals
Beta-blockers before surgery appear associated with lower risk of heart-related events Giving beta-blocker medication to patients with heart disease undergoing noncardiac surgery appears to be associated with a lower risk of death and major adverse cardiovascular events (MACE) 30 days after surgery in patients with heart failure (HF) or a recent myocardial infarction (MI, heart attack), according to a study published by JAMA Internal Medicine, a JAMA Network publication.

The effect of beta-blockers on the cardiac risk of noncardiac surgery has been controversial, with clinical guidelines encouraging their use amidst criticism that the evidence supporting the practice is weak, the authors write in the study background. These are beta-blockers given by physicians to patients at the time of surgery, not the beta-blockers patients are prescribed to take as a maintenance medication to treat chronic heart disease.

Charlotte Andersson, M.D., Ph.D., of the University Hospital of Copenhagen, Denmark, and colleagues identified patients in nationwide Danish registries who had ischemic heart disease (prior heart attack, angina) with or without HF and with or without a history of MI who underwent noncardiac surgery between October 2004 and December 2009. Researchers measured the association between beta-blocker use and MACE and all-cause mortality.

Of the 28,263 patients with heart disease who had surgery, 7,990 (28.3 percent) had HF and 20,273 (71.1 percent) did not. Beta (β)-blockers were used in 4,262 (53.3 percent) patients with HF and in 7,419 (36.6 percent) patients without HF.

The study findings suggest that among patients with HF, using beta-blockers was associated with a lower risk of MACE and mortality, but among patients without HF there was no association between beta-blocker use and MACE or mortality. Among patients without HF, beta-blocker use was associated with a lower risk of MACE and mortality among those who had a recent MI within the last two years.

"In conclusion, use of β-blockers among patients with ischemic heart disease and HF or recent MI undergoing noncardiac surgery is associated with a substantially decreased risk of major adverse cardiovascular events and all-cause mortality within 30 days after surgery," the authors conclude. (JAMA Intern Med. Published online November 18, 2013. doi:10.1001/jamainternmed.2013.11349. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: An author disclosed an honorarium. This study was supported by a grant from the Danish Agency for Science, Technology and Innovation. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Commentary: Perioperative Beta-Blockers Revisited In a related commentary, Seamus P. Whelton, M.D., M.P.H., and Sandeep Bansal, M.D., M.P.H., of The Johns Hopkins School of Medicine, Baltimore, write: "In summary, the authors should be congratulated for their thoughtful analysis and interpretation of the perioperative administration of β-blocker therapy in this large cohort of patients with ischemic heart disease."

"The results from this retrospective cohort study can help to inform current practice while also underscoring the need for a large-scale, prospective, randomized clinical trial to more definitively answer this important question," they continue.

"This study by Andersson et al adds to the growing body of evidence questioning the widely held dogma that perioperative β-blocker therapy is 'good for what ails you.' Instead, the astute clinician may need to exercise more judgment in selectively prescribing these medications. In the end, we should not be too surprised that even something as instinctive and habitual as perioperative β-blocker therapy for patients with ischemic heart disease must be prescribed in a judicious and personalized manner," they conclude. (JAMA Intern Med. Published online November 18, 2013. doi:10.1001/jamainternmed.2013.11341. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

### END


ELSE PRESS RELEASES FROM THIS DATE:

Poorer, rural counties have lower CPR training rates

2013-11-19
Poorer, rural counties have lower CPR training rates Cardiopulmonary resuscitation (CPR) training appears to be lower in more rural counties, those with higher proportions of black and Hispanic residents and lower household incomes, and in the South, Midwest ...

Drinking more milk as a teenager does not lower risk of hip fracture later

2013-11-19
Drinking more milk as a teenager does not lower risk of hip fracture later Drinking more milk as a teenager apparently does not lower the risk of hip fracture as an older adult and instead appears to increase that risk for men, according to a study published by ...

Preterm birth risk increases for pregnant women exposed to phthalates

2013-11-19
Preterm birth risk increases for pregnant women exposed to phthalates The odds of preterm delivery appear to increase for pregnant women exposed to phthalates, chemicals people are exposed to through contaminated food and water and in a variety of products ...

Gene plays major role in suppressing cancer

2013-11-19
Gene plays major role in suppressing cancer Adelaide researchers have found that a specific gene plays an important role in suppressing lymphoma, a type of blood cell cancer. The caspase-2 gene is related to a family of proteins that are essential for ...

Tackling early socioeconomic inequality as important as encouraging smoking cessation

2013-11-19
Tackling early socioeconomic inequality as important as encouraging smoking cessation Although health behaviours such as smoking are directly linked to the majority of early deaths in the UK, tackling these individual factors fails to address the underlying ...

Bacteria recycle broken DNA

2013-11-19
Bacteria recycle broken DNA Bacteria recycle broken DNA that bacteria can take up small as well as large pieces of old DNA from this scrapheap and include it in their own genome. This discovery may have major consequences – both in connection ...

A vexing math problem finds an elegant solution

2013-11-19
A vexing math problem finds an elegant solution ITHACA, N.Y. – A famous math problem that has vexed mathematicians for decades has met an elegant solution by Cornell University researchers. Graduate student Yash Lodha, working with Justin Moore, professor of mathematics, ...

Modeling of internal friction adds new wrinkle to realistic simulation of cloth behavior

2013-11-19
Modeling of internal friction adds new wrinkle to realistic simulation of cloth behavior Disney Researchers lead international collaboration Most people try to keep clothing wrinkle free, but computer graphic artists, striving for realism in computer simulations, take ...

Men with prostate cancer who ate a low-fat fish oil diet showed changes in their cancer tissue

2013-11-19
Men with prostate cancer who ate a low-fat fish oil diet showed changes in their cancer tissue For prostate cancer patients, it's a case of you are what you eat Men with prostate cancer who ate a low-fat diet and took fish oil supplements ...

UT researchers use simple scaling theory to better predict gas production in barnett shale wells

2013-11-19
UT researchers use simple scaling theory to better predict gas production in barnett shale wells AUSTIN, Texas — Researchers at The University of Texas at Austin have developed a simple scaling theory to estimate gas production from hydraulically fractured ...

LAST 30 PRESS RELEASES:

New theory reveals the shape of a single photon 

We could soon use AI to detect brain tumors

TAMEST recognizes Lyda Hill and Lyda Hill Philanthropies with Kay Bailey Hutchison Distinguished Service Award

Establishment of an immortalized red river hog blood-derived macrophage cell line

Neural networks: You might not need to buy every ticket to win the lottery

Healthy New Town: Revitalizing neighborhoods in the wake of aging populations

High exposure to everyday chemicals linked to asthma risk in children

How can brands address growing consumer scepticism?

New paradigm of quantum information technology revealed through light-matter interaction!

MSU researchers find trees acclimate to changing temperatures

World's first visual grading system developed to combat microplastic fashion pollution

Teenage truancy rates rise in English-speaking countries

Cholesterol is not the only lipid involved in trans fat-driven cardiovascular disease

Study: How can low-dose ketamine, a ‘lifesaving’ drug for major depression, alleviate symptoms within hours? UB research reveals how

New nasal vaccine shows promise in curbing whooping cough spread

Smarter blood tests from MSU researchers deliver faster diagnoses, improved outcomes

Q&A: A new medical AI model can help spot systemic disease by looking at a range of image types

For low-risk pregnancies, planned home births just as safe as birth center births, study shows

Leaner large language models could enable efficient local use on phones and laptops

‘Map of Life’ team wins $2 million prize for innovative rainforest tracking

Rise in pancreatic cancer cases among young adults may be overdiagnosis

New study: Short-lived soda tax reinforces alternative presumptions on tax impacts on consumer behaviors

Fewer than 1 in 5 know the 988 suicide lifeline

Semaglutide eligibility across all current indications for US adults

Can podcasts create healthier habits?

Zerlasiran—A small-interfering RNA targeting lipoprotein(a)

Anti-obesity drugs, lifestyle interventions show cardiovascular benefits beyond weight loss

Oral muvalaplin for lowering of lipoprotein(a)

Revealing the hidden costs of what we eat

New therapies at Kennedy Krieger offer effective treatment for managing Tourette syndrome

[Press-News.org] Beta-blockers before surgery appear associated with lower risk of heart-related events